Physician profile
Michael Jin Casey
NPI 1194991026
$4,783.13
in general payments reported to CMS, 2019-2025
7 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,207 · 2021: $12.98 · 2022: $138 · 2023: $22.69 · 2024: $194 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $4,206.71 | 2019 | |
| Amgen INC. | $173.66 | 2025 | Krystexxa, Tavneos |
| Stryker Corporation | $168.44 | 2024 | Target, Trevo |
| Veloxis Pharmaceuticals, INC. | $119.79 | 2022 | |
| Mallinckrodt Hospital Products INC. | $48.50 | 2023-2024 | Terlivaz, Acthar |
| Apellis Pharmaceuticals, INC. | $35.15 | 2025 | Empaveli |
| Astrazeneca Pharmaceuticals LP | $30.88 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.